Cumulative Axim Biotechnologies Inc 's Working Capital Ratio for Trailing Twelve Months Period

AXIM's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth

Select the Comparisons :

None ▼

Select the Ratio:

Working Capital Ratio for Trailing Twelve Months Period ▼

None ▼

Working Capital Ratio for Trailing Twelve Months Period ▼

AXIM Working Capital Ratio for Trailing Twelve Months Period	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Current Liabilities Growth	98.33 %	98.75 %	155.88 %	72.49 %	-45.89 %
Y / Y Current Assets Growth	-49.16 %	-56.74 %	-19.37 %	-10.73 %	-55.59 %
Working Capital Ratio for Trailing Twelve Months Period	0.14	0.18	0.23	0.32	0.4
Total Ranking	# 4079	# 5179	# 5162	# 5399	# 4287
Seq. Current Liabilities Growth	16.66 %	-19.33 %	30.23 %	61.83 %	16.9 %
Seq. Current Assets Growth	42.68 %	-66.86 %	-15.54 %	27.31 %	21.42 %

AXIM Segments >> Back to AXIM Financial Strength Comparisons >> Compare AXIM Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2022

On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $3 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.14 below Axim Biotechnologies Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 505 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Axim Biotechnologies Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about AXIM
Working Capital Ratio AXIM in the most recent quarter

Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within:	No.
Industry	# 506
Sector	# 1059
S&P 500	# 4137

Working Capital Ratio for Trailing Twelve Months Period Statistics
High	Average	Low
0.7	0.38	0.14
(Sep 30 2019)

Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry	Working Capital Ratio for Trailing Twelve Months Period
American Bio Medica Corporation	0.36
Nascent Biotech Inc	0.35
Statera Biopharma Inc fka Cytocom Inc	0.32
Provectus Biopharmaceuticals Inc	0.29
Musclepharm Corporation	0.28
Evofem Biosciences Inc	0.26
Ainos Inc	0.24
Bespoke Extracts Inc.	0.23
Theralink Technologies Inc	0.22
Arctos Northstar Acquisition Corp	0.21
Nanomix Corporation	0.21
Agex Therapeutics Inc	0.20
Immune Therapeutics Inc	0.20
Khosla Ventures Acquisition Co	0.18
Axim Biotechnologies Inc	0.16
Rapid Therapeutic Science Laboratories Inc	0.15
Bioxytran Inc	0.13
Rebus Holdings Inc	0.09
Sangui Biotech International Inc	0.06
Northwest Biotherapeutics inc	0.06
Regen Biopharma Inc	0.05
Bioadaptives Inc	0.04
Q Biomed inc	0.04
Neuropathix Inc.	0.04
Cell Source Inc	0.04
Skinvisible Inc.	0.03
Wellness Center Usa Inc	0.03


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar ARL's Profile Stock Price ARL's Financials Business Description Fundamentals Charts & Quotes ARL's News Suppliers ARL's Competitors Customers & Markets Economic Indicators ARL's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

Cumulative Axim Biotechnologies Inc 's Working Capital Ratio for Trailing Twelve Months Period

AXIM Working Capital Ratio for Trailing Twelve Months Period